GPO Plus, Inc.
GPOX
$0.035
$0.000.00%
| Weiss Ratings | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.56 | |||
| Price History | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.17% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -17.65% | |||
| 90-Day Total Return | -30.42% | |||
| Year to Date Total Return | -12.50% | |||
| 1-Year Total Return | -74.17% | |||
| 2-Year Total Return | -82.23% | |||
| 3-Year Total Return | -91.76% | |||
| 5-Year Total Return | -92.71% | |||
| 52-Week High % Change | -76.67% | |||
| 52-Week Low % Change | 34.62% | |||
| Price | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.15 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Jan 30, 2025 | |||
| 52-Week High Price (Date) | Apr 01, 2024 | |||
| Valuation | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.02M | |||
| Enterprise Value | 6.31M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.08 | |||
| Earnings Per Share Growth | -30.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.44 | |||
| Price/Book (Q) | -0.32 | |||
| Enterprise Value/Revenue (TTM) | 1.38 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -1.96 | |||
| Enterprise Value/EBIT | -1.92 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 57.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 840 1020 | |||
| Address | 3571 East Sunset Road Las Vegas, NV 89120 | |||
| Website | gpoplus.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -72.11% | |||
| Profit Margin | -85.80% | |||
| Management Effectiveness | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -292.92% | |||
| Return on Equity | -- | |||
| Income Statement | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.56M | |||
| Total Revenue (TTM) | 4.56M | |||
| Revenue Per Share | $0.08 | |||
| Gross Profit (TTM) | 897.90K | |||
| EBITDA (TTM) | -3.22M | |||
| EBIT (TTM) | -3.29M | |||
| Net Income (TTM) | -3.92M | |||
| Net Income Avl. to Common (TTM) | -3.92M | |||
| Total Revenue Growth (Q YOY) | -2.33% | |||
| Earnings Growth (Q YOY) | 39.98% | |||
| EPS Diluted (TTM) | -0.08 | |||
| EPS Diluted Growth (Q YOY) | 54.91% | |||
| Balance Sheet | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 253.90K | |||
| Total Preferred Equity (Q) | 1.92 | |||
| Total Equity (Q) | -4.45M | |||
| Current Ratio (Q) | 0.052 | |||
| Book Value Per Share (Q) | -$0.11 | |||
| Total Assets (Q) | 603.20K | |||
| Total Current Liabilities (Q) | 4.93M | |||
| Total Debt (Q) | 2.39M | |||
| Total Liabilities (Q) | 5.05M | |||
| Total Common Equity (Q) | -6.36M | |||
| Cash Flow | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -99.40K | |||
| Cash from Financing (TTM) | 1.12M | |||
| Net Change in Cash (TTM) | -57.70K | |||
| Levered Free Cash Flow (TTM) | 267.20K | |||
| Cash from Operations (TTM) | -1.08M | |||
